bioMérieux sees strong sales growth in first half of 2016

Published: 12-Sep-2016
Finance Analysis

Expanded business portfolio and launch of new database and reagent kits boosts company momentum


bioMérieux sales in the first half of the 2016 financial year rose by 10.9% at constant exchange rates to €1,001m. The company says that this robust sales momentum offset the negative currency effect and predicts organic sales growth for the full year at or above the higher end of the previously targeted 6-8% range.

'Backed by its expanded business portfolio and broad global market footprint, bioMérieux has accelerated its organic sales growth and improved its operating margins,' said Alexandre Mérieux, Chief Executive Officer.

In July the company launched the first CE-marked database and reagent kits for the identification of mycobacteria, Nocardia, and moulds in a MALDI-TOF (Matrix Assisted Laser Desorption Ionization – Time Of Flight) Mass Spectrometry System. This development further enhances the VITEK MS system’s performance by adding 297 new species including identification of the Mycobacterium tuberculosis (TB) group, 45 species of the most frequent non-tuberculous mycobacteria (NTM), and 48 of the most medically important moulds.

The VITEK MS extended database now enables the identification within minutes of 1,046 species representing 15,172 distinct strains of bacteria, yeasts and moulds. The convenient, user-friendly reagent kits for use with this highly automated mass spectrometry system provide lab professionals with extremely reliable results.

Mycobacteria, Nocardia and moulds, which cause tuberculosis, lung and bone infections, and other serious organ infections, are difficult to identify organisms, requiring days or weeks of specific culture conditions for appropriate growth and subsequent advanced methods for reliable identification to species level. The updated VITEK MS system, however, can now offer simple, rapid and reliable identification of these pathogens.

'As a world leader in microbiology, one of our priorities is to develop high medical value solutions which allow rapid and accurate detection of micro-organisms,' said François Lacoste, bioMérieux Corporate VP, Clinical Unit. 'Introducing the VITEK MS new features for the rapid identification of these three additional groups of important pathogens enhances our diagnostic solutions for the benefit of healthcare providers, with the ultimate goal of improving patient outcomes.'

  • Companies:
  • bioMerieux
See more

You may also like

Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

Read more
The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit for purpose once installed in your facility
  2. Microbiological monitoring: Adapting to new rapid methods regulatory demands Dr Wan Li Low from Cherwell takes a look at the shift towards Rapid Microbiology Methods (RMM) and their validation
  3. Syntegon launches new "Settle Plate Changer" for automated viable monitoring Syntegon has patented its new Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process
  4. Germfree launches Smarthood for sterile compounding The cleanroom containment expert has launched Smarthood to integrate IV production workflow software, hardware, and peripherals directly into the hood
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Phoenix Controls launches dynamic airflow management solution for critical environments The platform uses specialised venturi valves and sensors to create automated airflow in response to environmental fluctuations in cleanrooms and other controlled environments

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue
Analysis

bioMérieux and JMI partner to fight antimicrobial resistance

The two firms have announced a six year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR
Cleaning

bioMérieux launches assay for simultaneous Salmonella and Listeria detection

France-based bioMérieux has introduced GENE-UP ENVIROPRO that simultaneously detects both Salmonella and Listeria through a single enriched sample with PCR confirmation
Finance

bioMerieux acquires molecular testing company

The acquisition of the molecular testing platform, Veriflow, will compliment bioMérieux’s Gene-up system
Analysis

bioMérieux launches automated diagnostic solution for microbial detection

EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance

BioMérieux acquires Hyglos for a total consideration of €24m

Expands its offering for the detection of endotoxins in pharmaceutical products
Infection Control

bioMérieux and Illumina launch revolutionary next-generation sequencing service

bioMérieux EpiSeq is an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections
Subscribe now